[1]American Psychiatric Association.Sleep-Wake Disorders. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition (DSM5).Arlington.VA: American Psychiatric Association 2013.
[2]Buysse DJ. Insomnia. J JAMA The Journal of the American Medical Association. 2013; 309(7):706–716.
[3]Morin CM.Chronic insomnia. J Lancet (London, England). 2012;379(9821):1129–1141.
[4]China Sleep Research Association. Guidelines for the diagnosis and treatment of insomnia in China. J National Medical Journal of China. 2017;97(24):1844–1856.
[5]Barbara P, Mannino DM. Do insomnia complaints cause hypertension or cardiovascular disease?. J Journal of Clinical Sleep Medicine Jcsm Official Publication of the American Academy of Sleep Medicine. 2007;3(5):489.
[6]Scalo J, Desai P, Rascati K. Insomnia, hypnotic use, and health-related quality of life in a nationally representative sample. J Quality of Life Research. 2015;24(5):1223–1233.
[7]Parthasarathy S, Vasquez MM, Halonen M, et al. Persistent insomnia is associated with mortality risk. J The American Journal of Medicine. 2015;128(3):268–275.
[8]Daley M, Morin CM, LeBlanc M, et al. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep. 2009;32:55–64.
[9]Morgenthaler T, Kramer M, Alessi C, et al. Practice Parameters for the Psychological and Behavioral Treatment of Insomnia: An Update. An American Academy of Sleep Medicine Report. J Sleep. 2006;29(11):1415–1419.
[10]Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. 2008;4(5):487–504.
[11]Qaseem A, Kansagara D, Forciea MA, et al. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. J Annals of internal medicine. 2016;165(2):125–133.
[12]Ree M, Junge M, Cunnington D. Australasian Sleep Association position statement regarding the use of psychological/behavioral treatments in the management of insomnia in adults. J Sleep Medicine. 2017;36:S43–47.
[13]Riemann D, Perlis ML. The treatments of chronic insomnia: A review of benzodiazepine receptor agonists and psychological and behavioral therapies. J Sleep Medicine Reviews. 2009;13(3):205–214.
[14]Health N I O. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13–15, 2005. J Sleep. 2005;28(9):1049.
[15]Buscemi N, Vandermeer B, Friesen C, et al. The Efficacy and Safety of Drug Treatments for Chronic Insomnia in Adults: A Meta-analysis of RCTs. J Journal of General Internal Medicine. 2007;22(9):1335–1350.
[16]Scharf MB, Roth PB, Dominguez RA, et al. Estazolam and Flurazepam: A Multicenter, Placebo-Controlled Comparative Study in Outpatients with Insomnia. J The Journal of Clinical Pharmacology. 1990;30(5):461–467.
[17]Schroeck JL, Ford J, Conway EL, et al. Review of Safety and Efficacy of Sleep Medicines in Older Adults. J Clinical therapeutics. 2016;38(11):2340–2372.
[18]Bertisch SM, Herzig SJ, Winkelman JW, et al. National Use of Prescription Medications for Insomnia: NHANES 1999–2010. J Sleep. 2014;37(2):343–349.
[19]Walsh JK, Roth T. Kryger MH, Roth T, Dement WC. Pharmacologic treatment of insomnia: benzodiazepine receptor agonists. Principles and Practices of Sleep Medicine 5th ednGlendenning, Australia: Saunders. 2011;905–915.
[20]Morin CM, Gaulier B, Barry T. Patients’ acceptance of psychological and pharmacological therapies for insomnia. J Sleep. 1992;15(4):302–305.
[21]Vincent N, Lionberg C. Treatment preference and patient satisfaction in chronic insomnia. J Sleep. 2001;24(4):411–417.
[22]Edinger JD, Sampson WS. A Primary Care “Friendly” Cognitive Behavioral Insomnia Therapy. J Sleep. 2003;26(2):177–182.
[23]Kaptchuk TJ. Acupuncture: theory, efficacy, and practice. J Annals of internal medicine.2002;136(5):374–383.
[24]Listed NA. NIH Consensus Conference. Acupuncture. J Jama. 1998;280(17):1518–1524.
[25]Liu Q, Wang XJ, Zhao Y, et al. Evaluate Efficacy,Intervention-Level of Acupuncture Therapy Based on Meta-Analysis of Ordinal Data: Primary Insomnia. J Liaoning Journal of Traditional Chinese Medicine. 2017;1:134–137.
[26]Cheng GL, Qian YF, Li J, et al. Review about the Mechanism of Insomnia. J World Journal of Sleep Medicine. 2016;3:174–179.
[27]Ochoa-Sanchez R, Comai S, Lacoste B, et al. Promotion of Non-Rapid Eye Movement Sleep and Activation of Reticular Thalamic Neurons by a Novel MT2 Melatonin Receptor Ligand. J Journal of Neuroscience. 2011;31(50):18439–18452.
[28]Cole P. ITI–007. 5-HT2A receptor antagonist, dopamine D2 receptor modulator, treatment of schizophrenia, treatment of insomnia. J Drugs of the Future. 2015;40 (10):643.
[29]Rosenberg R, Seiden DJ, Hull SG, et al. APD125, a selective serotonin 5-HT(2A) receptor inverse agonist, significantly improves sleep maintenance in primary insomnia. J Sleep. 2008;31(12):1663–1671.
[30]Elder GJ, Wetherell MA, Barclay NL, et al. The cortisol awakening response Applications and implications for sleep medicine. J Sleep Medicine Reviews. 2014;18(3):215–224.
[31]Kimura M, Müller-Preuss P, Lu A, et al.Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep. J Molecular psychiatry. 2010;15(2):154–165
[32]Xiao X, Wei JJ, Li WJ, et al. Mechanism Analysis of the Antidepressant Effect of Acupuncture by Regulating the HPA Axis. J Shanghai Journal of Acupuncture and Moxibustion. 2016;35(6):758–760.
[33]Jia BH, Li ZG, Shi YJ, et al. Effect of Electroacupuncture on Changes of Behavior and Some Relat ed Hormones of Hypothalamus-pituitary-adrenal Axis in Chronic Stress Model Rats. J Acupuncture Research. 2004;4:252–256.
[34]Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J BMJ. 2011;9(8):672–677.
[35]Dorsher PT. The 2001 STRICTA Recommendations for Reporting Acupuncture Research: A Review with Implications for Improving Controlled Clinical Trial Design. J Altern Complement Med. 2009;15(2):147–151.
[36]Cheuk DK, Yeung WF, Chung KF, et al. Acupuncture for insomnia. J Cochrane database of systematic reviews. 2007;9(3):CD005472.
[37]He W, Tong Y, Zhao Y, et al. Review of controlled clinical trials on acupuncture versus sham acupuncture in Germany. J Journal of Traditional Chinese Medicine. 2013; 33(3):403–407.
[38]Streitberger K, Kleinhenz J. Introducing a placebo needle into acupuncture research. J Complementary Therapies in Medicine. 1998;7(9125):364–365.